Company: LBRX
Filing Date: 2025-08-22
Form Type: S-1
Source: 0001193125-25-186467
Chunk: 14

Company: LB PHARMACEUTICALS INC
Filing Date: 2025-08-22
Form: S-1
Chunk 14
---
 Stock              
 Incentive Plan, as amended, or the 2023 Plan, as of June 30, 2025, at a weighted-average exercise price of $1.50 per share; |

| • |     | 779,500 shares of common stock issuable upon the exercise of outstanding stock options under our 2018 Stock     
 Incentive Plan, or the 2018 Plan, as of June 30, 2025, at a weighted-average exercise price of $2.38 per share; |

| • |     | 290,000 shares of common stock issuable upon the exercise of outstanding stock options under our 2017 Stock     
 Incentive Plan, or the 2017 Plan, as of June 30, 2025, at a weighted-average exercise price of $1.79 per share; |

8

| • |     | 695,961 shares of our common stock issuable upon the exercise of Class A common stock warrants outstanding                                                              
 as of June 30, 2025, with an exercise price of $0.01 per share, as more fully described in the section titled “Description of Capital Stock—Warrants—Class A Warrants;” |

| • |     | 882,948 shares of our common stock issuable upon the exercise of Class B common stock warrants outstanding                                                              
 as of June 30, 2025, with an exercise price of $0.01 per share, as more fully described in the section titled “Description of Capital Stock—Warrants—Class B Warrants;” |

| • |     | 1,528,632 shares of our common stock issuable to Maxim Partners LLC upon the exercise of common stock warrants                                                                    
 outstanding as of June 30, 2025, with an exercise price of $0.01 per share, as more fully described in the section titled “Description of Capital Stock—Warrants—Maxim Warrants;” |

| • |     | 71,761 shares of our common stock issuable upon the exercise of Series B-1 common stock warrants outstanding as                                                         
 of June 30, 2025, with an exercise price of $0.01 per share, as more fully described in the section titled “Description of Capital Stock—Warrants—Series B-1 Warrants;” |

| • |     | 98,456 shares of our common stock issuable upon the exercise of New Series B common stock warrants outstanding as                                                         
 of June